バイオ医薬品自動化の世界市場：インサイト・予測

• 英文タイトル：Global Automation in Biopharmaceutical Market Insights, Forecast to 2025

• レポートコード：QYR9ST00054 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：自動車・運送

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※本調査レポートでは、世界のバイオ医薬品自動化市場について調査・分析し、以下の構成でお届け致します。バイオ医薬品自動化の種類別には、臨床段階自動化、創薬段階自動化に、用途別には、研究開発、臨床に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別バイオ医薬品自動化売上データ ・地域別バイオ医薬品自動化市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別バイオ医薬品自動化市場規模：臨床段階自動化、創薬段階自動化 ・用途別バイオ医薬品自動化市場規模：研究開発、臨床 ・主要メーカーの企業情報：Danaher、GE、PerkinElmer、Tecan Trading、Thermo Fisher Scientific、Bruker、Peak Analysis & Automation、Waters、Capsugel、RheoSense、Eirechrom、BioProcess International、Novasep ・バイオ医薬品自動化の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ...

The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”
According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer’s disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
Global Automation in Biopharmaceutical market size will reach 1590 million US$ by 2025, from 1040 million US$ in 2018, at a CAGR of 6.2% during the forecast period. In this study, 2018 has been considered as the base year and 2019-2025 as the forecast period to estimate the market size for Automation in Biopharmaceutical.

This industry study presents the global Automation in Biopharmaceutical market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Automation in Biopharmaceutical production, revenue and market share by manufacturers, key regions and type;
The consumption of Automation in Biopharmaceutical in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders Danaher, GE, etc.

The following manufacturers are covered in this report:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep

Automation in Biopharmaceutical Breakdown Data by Type
Clinical stage automation
Drug discovery stage automation
Automation in Biopharmaceutical Breakdown Data by Application
Research and Development
Clinical

Automation in Biopharmaceutical Production by Region
United States
Europe
China
Japan
South Korea
India
Other Regions

Automation in Biopharmaceutical Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Automation in Biopharmaceutical status and future forecast，involving, production, revenue, consumption, historical and forecast.
To present the key Automation in Biopharmaceutical manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
To segment the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Automation in Biopharmaceutical :
History Year: 2014 – 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year: 2019 – 2025

This report includes the estimation of market size for value (million USD) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Automation in Biopharmaceutical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Study Coverage
1.1 Automation in Biopharmaceutical Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type
1.4.2 Clinical stage automation
1.4.3 Drug discovery stage automation
1.5 Market by Application
1.5.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Application
1.5.2 Research and Development
1.5.3 Clinical
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Automation in Biopharmaceutical Market Size
2.1.1 Global Automation in Biopharmaceutical Revenue 2014-2025
2.1.2 Global Automation in Biopharmaceutical Production 2014-2025
2.2 Automation in Biopharmaceutical Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Automation in Biopharmaceutical Manufacturers
2.3.2.1 Automation in Biopharmaceutical Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Automation in Biopharmaceutical Product Offered
2.3.2.3 Date of Manufacturers Enter into Automation in Biopharmaceutical Market
2.4 Key Trends for Automation in Biopharmaceutical Markets & Products

3 Market Size by Manufacturers
3.1 Automation in Biopharmaceutical Production by Manufacturers
3.1.1 Automation in Biopharmaceutical Production by Manufacturers
3.1.2 Automation in Biopharmaceutical Production Market Share by Manufacturers
3.2 Automation in Biopharmaceutical Revenue by Manufacturers
3.2.1 Automation in Biopharmaceutical Revenue by Manufacturers (2014-2019)
3.2.2 Automation in Biopharmaceutical Revenue Share by Manufacturers (2014-2019)
3.3 Automation in Biopharmaceutical Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Automation in Biopharmaceutical Production by Regions
4.1 Global Automation in Biopharmaceutical Production by Regions
4.1.1 Global Automation in Biopharmaceutical Production Market Share by Regions
4.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Regions
4.2 United States
4.2.1 United States Automation in Biopharmaceutical Production
4.2.2 United States Automation in Biopharmaceutical Revenue
4.2.3 Key Players in United States
4.2.4 United States Automation in Biopharmaceutical Import & Export
4.3 Europe
4.3.1 Europe Automation in Biopharmaceutical Production
4.3.2 Europe Automation in Biopharmaceutical Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Automation in Biopharmaceutical Import & Export
4.4 China
4.4.1 China Automation in Biopharmaceutical Production
4.4.2 China Automation in Biopharmaceutical Revenue
4.4.3 Key Players in China
4.4.4 China Automation in Biopharmaceutical Import & Export
4.5 Japan
4.5.1 Japan Automation in Biopharmaceutical Production
4.5.2 Japan Automation in Biopharmaceutical Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Automation in Biopharmaceutical Import & Export
4.6 South Korea
4.6.1 South Korea Automation in Biopharmaceutical Production
4.6.2 South Korea Automation in Biopharmaceutical Revenue
4.6.3 Key Players in South Korea
4.6.4 South Korea Automation in Biopharmaceutical Import & Export
4.7 India
4.7.1 India Automation in Biopharmaceutical Production
4.7.2 India Automation in Biopharmaceutical Revenue
4.7.3 Key Players in India
4.7.4 India Automation in Biopharmaceutical Import & Export
4.8 Other Regions

5 Automation in Biopharmaceutical Consumption by Regions
5.1 Global Automation in Biopharmaceutical Consumption by Regions
5.1.1 Global Automation in Biopharmaceutical Consumption by Regions
5.1.2 Global Automation in Biopharmaceutical Consumption Market Share by Regions
5.2 North America
5.2.1 North America Automation in Biopharmaceutical Consumption by Application
5.2.2 North America Automation in Biopharmaceutical Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Automation in Biopharmaceutical Consumption by Application
5.3.2 Europe Automation in Biopharmaceutical Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Automation in Biopharmaceutical Consumption by Application
5.4.2 Asia Pacific Automation in Biopharmaceutical Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Automation in Biopharmaceutical Consumption by Application
5.5.2 Central & South America Automation in Biopharmaceutical Consumption by Country
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Automation in Biopharmaceutical Consumption by Application
5.6.2 Middle East and Africa Automation in Biopharmaceutical Consumption by Countries
5.6.3 GCC Countries
5.6.4 Egypt
5.6.5 South Africa

6 Market Size by Type
6.1 Global Automation in Biopharmaceutical Production by Type
6.2 Global Automation in Biopharmaceutical Revenue by Type
6.3 Automation in Biopharmaceutical Price by Type

7 Market Size by Application
7.1 Overview
7.2 Global Automation in Biopharmaceutical Breakdown Dada by Application
7.2.1 Global Automation in Biopharmaceutical Consumption by Application
7.2.2 Global Automation in Biopharmaceutical Consumption Market Share by Application (2014-2019)

8 Key Industry Players
8.1 Danaher
8.1.1 Danaher Company Details
8.1.2 Production and Revenue of Automation in Biopharmaceutical
8.1.3 Danaher Automation in Biopharmaceutical Product Description
8.1.4 SWOT Analysis
8.1.5 Danaher Economic Activity & Plans
8.2 GE
8.2.1 GE Company Details
8.2.2 Production and Revenue of Automation in Biopharmaceutical
8.2.3 GE Automation in Biopharmaceutical Product Description
8.2.4 SWOT Analysis
8.2.5 GE Economic Activity & Plans
8.3 PerkinElmer
8.3.1 PerkinElmer Company Details
8.3.2 Production and Revenue of Automation in Biopharmaceutical
8.3.3 PerkinElmer Automation in Biopharmaceutical Product Description
8.3.4 SWOT Analysis
8.3.5 PerkinElmer Economic Activity & Plans
8.4 Tecan Trading
8.4.1 Tecan Trading Company Details
8.4.2 Production and Revenue of Automation in Biopharmaceutical
8.4.3 Tecan Trading Automation in Biopharmaceutical Product Description
8.4.4 SWOT Analysis
8.4.5 Tecan Trading Economic Activity & Plans
8.5 Thermo Fisher Scientific
8.5.1 Thermo Fisher Scientific Company Details
8.5.2 Production and Revenue of Automation in Biopharmaceutical
8.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product Description
8.5.4 SWOT Analysis
8.5.5 Thermo Fisher Scientific Economic Activity & Plans
8.6 Bruker
8.6.1 Bruker Company Details
8.6.2 Production and Revenue of Automation in Biopharmaceutical
8.6.3 Bruker Automation in Biopharmaceutical Product Description
8.6.4 SWOT Analysis
8.6.5 Bruker Economic Activity & Plans
8.7 Peak Analysis & Automation
8.7.1 Peak Analysis & Automation Company Details
8.7.2 Production and Revenue of Automation in Biopharmaceutical
8.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Product Description
8.7.4 SWOT Analysis
8.7.5 Peak Analysis & Automation Economic Activity & Plans
8.8 Waters
8.8.1 Waters Company Details
8.8.2 Production and Revenue of Automation in Biopharmaceutical
8.8.3 Waters Automation in Biopharmaceutical Product Description
8.8.4 SWOT Analysis
8.8.5 Waters Economic Activity & Plans
8.9 Capsugel
8.9.1 Capsugel Company Details
8.9.2 Production and Revenue of Automation in Biopharmaceutical
8.9.3 Capsugel Automation in Biopharmaceutical Product Description
8.9.4 SWOT Analysis
8.9.5 Capsugel Economic Activity & Plans
8.10 RheoSense
8.10.1 RheoSense Company Details
8.10.2 Production and Revenue of Automation in Biopharmaceutical
8.10.3 RheoSense Automation in Biopharmaceutical Product Description
8.10.4 SWOT Analysis
8.10.5 RheoSense Economic Activity & Plans
8.11 Eirechrom
8.12 BioProcess International
8.13 Novasep

9 Entry Strategy for Key Countries
9.1 Entry Strategy for United States Market
9.2 Entry Strategy for China Market
9.3 Entry Strategy for India Market

10 Production Forecasts
10.1 Automation in Biopharmaceutical Production and Revenue Forecast
10.1.1 Global Automation in Biopharmaceutical Production Forecast 2019-2025
10.1.2 Global Automation in Biopharmaceutical Revenue Forecast 2019-2025
10.2 Automation in Biopharmaceutical Production and Revenue Forecast by Regions
10.2.1 Global Automation in Biopharmaceutical Revenue Forecast by Regions
10.2.2 Global Automation in Biopharmaceutical Production Forecast by Regions
10.3 Automation in Biopharmaceutical Key Producers Forecast
10.3.1 United States
10.3.2 Europe
10.3.3 China
10.3.4 Japan
10.3.5 South Korea
10.3.6 India
10.4 Forecast by Type
10.4.1 Global Automation in Biopharmaceutical Production Forecast by Type
10.4.2 Global Automation in Biopharmaceutical Revenue Forecast by Type

11 Consumption Forecast
11.1 Automation in Biopharmaceutical Consumption Forecast by Application
11.2 Automation in Biopharmaceutical Consumption Forecast by Regions
11.3 North America Market Consumption Forecast
11.3.1 North America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
11.3.2 United States
11.3.3 Canada
11.3.4 Mexico
11.4 Europe Market Consumption Forecast
11.4.1 Europe Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
11.4.2 Germany
11.4.3 France
11.4.4 UK
11.4.5 Italy
11.4.6 Russia
11.5 Asia Pacific Market Consumption Forecast
11.5.1 Asia Pacific Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
11.5.2 China
11.5.3 Japan
11.5.4 South Korea
11.5.5 India
11.5.6 Australia
11.5.7 Indonesia
11.5.8 Thailand
11.5.9 Malaysia
11.5.10 Philippines
11.5.11 Vietnam
11.6 Central & South America Market Consumption Forecast
11.6.1 Central & South America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
11.6.2 Brazil
11.7 Middle East and Africa Market Consumption Forecast
11.7.1 Middle East and Africa Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
11.7.2 GCC Countries
11.7.3 Egypt
11.7.4 South Africa

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings in the Global Automation in Biopharmaceutical Study

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Automation in Biopharmaceutical Product Picture
Table Automation in Biopharmaceutical Key Market Segments in This Study
Table Key Manufacturers Automation in Biopharmaceutical Covered in This Study
Table Major Manufacturers Automation in Biopharmaceutical Sales to top 10 OEMs in 2018 (Supply Relationship)
Table Global Automation in Biopharmaceutical Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Automation in Biopharmaceutical Production Market Share 2014-2025
Figure Clinical stage automation Product Picture
Table Major Manufacturers of Clinical stage automation
Figure Drug discovery stage automation Product Picture
Table Major Manufacturers of Drug discovery stage automation
Table Global Automation in Biopharmaceutical Market Size Growth Rate by Application 2019-2025 (K MT)
Figure Research and Development
Figure Clinical
Figure Automation in Biopharmaceutical Report Years Considered
Figure Global Automation in Biopharmaceutical Revenue 2014-2025 (Million US$)
Figure Global Automation in Biopharmaceutical Production 2014-2025 (K MT)
Table Global Automation in Biopharmaceutical Market Size Growth Rate by Regions 2019-2025(K MT) & (Million US$)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Automation in Biopharmaceutical Manufacturing Base Distribution and Headquarters
Table Manufacturers Automation in Biopharmaceutical Product Offered
Table Date of Manufacturers Enter into Automation in Biopharmaceutical Market
Table Global Automation in Biopharmaceutical Production by Manufacturers (2014-2019) (K MT)
Table Global Automation in Biopharmaceutical Production Share by Manufacturers (2014-2019)
Figure Global Automation in Biopharmaceutical Production Share by Manufacturers in 2018
Table Automation in Biopharmaceutical Revenue by Manufacturers (2014-2019) (Million US$)
Figure Automation in Biopharmaceutical Value Share by Manufacturers in 2019
Table Automation in Biopharmaceutical Revenue Share by Manufacturers (2014-2019)
Table Automation in Biopharmaceutical Price by Manufacturers 2014-2019 (USD/MT)
Table Mergers & Acquisitions, Expansion Plans
Table Global Automation in Biopharmaceutical Production by Regions 2014-2019 (K MT)
Table Global Automation in Biopharmaceutical Production Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Production Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Production Market Share by Regions in 2018
Table Global Automation in Biopharmaceutical Revenue by Regions 2014-2019 (Million US$)
Table Global Automation in Biopharmaceutical Revenue Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Revenue Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Revenue Market Share by Regions in 2018
Figure United States Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure United States Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table United States Automation in Biopharmaceutical Import & Export
Figure Europe Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure Europe Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table Europe Automation in Biopharmaceutical Import & Export
Figure China Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure China Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table China Automation in Biopharmaceutical Import & Export
Figure Japan Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure Japan Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table Japan Automation in Biopharmaceutical Import & Export
Figure South Korea Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure South Korea Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table South Korea Automation in Biopharmaceutical Import & Export
Figure India Automation in Biopharmaceutical Production and Growth Rate 2014-2019 (K MT)
Figure India Automation in Biopharmaceutical Revenue and Growth Rate 2014-2019 (Million US$)
Table India Automation in Biopharmaceutical Import & Export
Table Global Automation in Biopharmaceutical Consumption by Regions 2014-2019 (K MT)
Table Global Automation in Biopharmaceutical Consumption Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Consumption Market Share by Regions 2014-2019
Figure Global Automation in Biopharmaceutical Consumption Market Share by Regions in 2018
Figure North America Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Table North America Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Figure 2018 North America Automation in Biopharmaceutical Consumption Market Share by Application
Table North America Automation in Biopharmaceutical Consumption by Countries (2014-2019) (K MT)
Figure 2018 North America Automation in Biopharmaceutical Consumption Market Share by Countries
Figure United States Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Canada Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Mexico Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Europe Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Table Europe Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Figure 2018 Europe Automation in Biopharmaceutical Consumption Market Share by Application
Table Europe Automation in Biopharmaceutical Consumption by Countries (2014-2019) (K MT)
Figure 2018 Europe Automation in Biopharmaceutical Consumption Market Share by Countries
Figure Germany Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure France Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure UK Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Italy Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Russia Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Asia Pacific Automation in Biopharmaceutical Consumption and Growth Rate (K MT)
Table Asia Pacific Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Table Asia Pacific Automation in Biopharmaceutical Consumption Market Share by Application (2014-2019) (K MT)
Table Asia Pacific Automation in Biopharmaceutical Consumption by Countries (2014-2019) (K MT)
Table Asia Pacific Automation in Biopharmaceutical Consumption Market Share by Countries (2014-2019) (K MT)
Figure China Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Japan Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Korea Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure India Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Australia Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Indonesia Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Thailand Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Malaysia Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Philippines Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Vietnam Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Central & South America Automation in Biopharmaceutical Consumption and Growth Rate (K MT)
Table Central & South America Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Figure 2018 Central & South America Automation in Biopharmaceutical Consumption Market Share by Application
Table Central & South America Automation in Biopharmaceutical Consumption by Countries (2014-2019) (K MT)
Figure Central & South America Automation in Biopharmaceutical Consumption Market Share by Countries
Figure Brazil Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Middle East and Africa Automation in Biopharmaceutical Consumption and Growth Rate (K MT)
Table Middle East and Africa Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Figure 2018 Middle East and Africa Automation in Biopharmaceutical Consumption Market Share by Application
Table Middle East and Africa Automation in Biopharmaceutical Consumption by Countries (2014-2019) (K MT)
Figure Middle East and Africa Automation in Biopharmaceutical Consumption Market Share by Countries
Figure GCC Countries Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure Egypt Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Figure South Africa Automation in Biopharmaceutical Consumption and Growth Rate (2014-2019) (K MT)
Table Global Automation in Biopharmaceutical Production by Type (2014-2019) (K MT)
Table Global Automation in Biopharmaceutical Production Share by Type (2014-2019)
Figure Global Automation in Biopharmaceutical Production Market Share by Type (2014-2019)
Figure Global Automation in Biopharmaceutical Production Market Share by Type in 2018
Table Global Automation in Biopharmaceutical Revenue by Type (2014-2019) (Million US$)
Table Global Automation in Biopharmaceutical Revenue Share by Type (2014-2019)
Figure Global Automation in Biopharmaceutical Revenue Market Share by Type (2014-2019)
Figure Global Automation in Biopharmaceutical Revenue Market Share by Type in 2018
Table Automation in Biopharmaceutical Price by Type 2014-2019 (USD/MT)
Table Global Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Table Global Automation in Biopharmaceutical Consumption by Application (2014-2019) (K MT)
Table Global Automation in Biopharmaceutical Consumption Share by Application (2014-2019)
Figure Global Automation in Biopharmaceutical Consumption Market Share by Application (2014-2019)
Figure Global Automation in Biopharmaceutical Value (Consumption) Market Share by Application (2014-2019)
Table Danaher Company Details
Table Danaher Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Danaher Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Danaher Automation in Biopharmaceutical Production Market Share in Global Market
Figure Danaher SWOT Analysis
Table GE Company Details
Table GE Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure GE Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure GE Automation in Biopharmaceutical Production Market Share in Global Market
Figure GE SWOT Analysis
Table PerkinElmer Company Details
Table PerkinElmer Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure PerkinElmer Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure PerkinElmer Automation in Biopharmaceutical Production Market Share in Global Market
Figure PerkinElmer SWOT Analysis
Table Tecan Trading Company Details
Table Tecan Trading Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Tecan Trading Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Tecan Trading Automation in Biopharmaceutical Production Market Share in Global Market
Figure Tecan Trading SWOT Analysis
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Thermo Fisher Scientific Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Thermo Fisher Scientific Automation in Biopharmaceutical Production Market Share in Global Market
Figure Thermo Fisher Scientific SWOT Analysis
Table Bruker Company Details
Table Bruker Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Bruker Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Bruker Automation in Biopharmaceutical Production Market Share in Global Market
Figure Bruker SWOT Analysis
Table Peak Analysis & Automation Company Details
Table Peak Analysis & Automation Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Peak Analysis & Automation Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Peak Analysis & Automation Automation in Biopharmaceutical Production Market Share in Global Market
Figure Peak Analysis & Automation SWOT Analysis
Table Waters Company Details
Table Waters Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Waters Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Waters Automation in Biopharmaceutical Production Market Share in Global Market
Figure Waters SWOT Analysis
Table Capsugel Company Details
Table Capsugel Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure Capsugel Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure Capsugel Automation in Biopharmaceutical Production Market Share in Global Market
Figure Capsugel SWOT Analysis
Table RheoSense Company Details
Table RheoSense Automation in Biopharmaceutical Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure RheoSense Automation in Biopharmaceutical Production Growth Rate (2014-2019)
Figure RheoSense Automation in Biopharmaceutical Production Market Share in Global Market
Figure RheoSense SWOT Analysis
Table Eirechrom Company Details
Table BioProcess International Company Details
Table Novasep Company Details
Table Entry Strategy for United States Market
Table Entry Strategy for China Market
Table Entry Strategy for India Market
Figure Global Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Global Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Global Automation in Biopharmaceutical Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Automation in Biopharmaceutical Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Automation in Biopharmaceutical Revenue Market Share Forecast by Regions 2019-2025
Table Global Automation in Biopharmaceutical Production Forecast by Regions 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Production Forecast by Regions 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Production Market Share Forecast by Regions 2019-2025
Figure United States Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure United States Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Figure Europe Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure Europe Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Figure China Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure China Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Figure Japan Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure Japan Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Figure South Korea Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure South Korea Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Figure India Automation in Biopharmaceutical Production Forecast 2019-2025 (K MT)
Figure India Automation in Biopharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Global Automation in Biopharmaceutical Production Forecast by Type 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Production Forecast by Type 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Production Market Share Forecast by Type 2019-2025
Table Global Automation in Biopharmaceutical Revenue Forecast by Type 2019-2025 (Million US$)
Figure Global Automation in Biopharmaceutical Revenue Forecast by Type 2019-2025 (Million US$)
Figure Global Automation in Biopharmaceutical Revenue Market Share Forecast by Type 2019-2025
Table Global Automation in Biopharmaceutical Consumption Forecast by Application 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Consumption Forecast by Application 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Consumption Market Share Forecast by Application 2019-2025
Table Global Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure Global Automation in Biopharmaceutical Consumption Market Share Forecast by Regions 2019-2025
Table North America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure United States Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Canada Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure MexicoAutomation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Table Europe Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure Germany Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure France Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure UK Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Italy Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Russia Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Table Asia Pacific Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure China Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Japan Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Korea Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure India Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Australia Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Indonesia Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Thailand Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Malaysia Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Philippines Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Vietnam Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Table Central & South America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure Brazil Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Table Middle East and Africa Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025 (K MT)
Figure Middle East and Africa Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure GCC Countries Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure Egypt Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Figure South Africa Automation in Biopharmaceutical Consumption Forecast 2019-2025 (K MT)
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---